Cancer Treatment Facilities Market Report 2025

The cancer treatment facilities market size has grown strongly in recent years. It will grow from $44.63 billion in 2024 to $48.27 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period was driven by a rising incidence of cancer, an expanding elderly population, greater awareness and early detection efforts, increased adoption of advanced treatment modalities, and higher overall healthcare spending.

The cancer treatment facilities market size is expected to see strong growth in the next few years. It will grow to 65.44 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The expected growth during the forecast period is fueled by expanded access to health insurance, rising demand for personalized treatment approaches, growth in medical tourism for cancer care, increased investments in cancer research and facility development, and greater integration of AI and digital health technologies. Key trends anticipated include innovations in radiation therapy, the use of artificial intelligence in oncology, adoption of robotic-assisted surgical systems, progress in personalized and genomic medicine, and advancements in imaging and diagnostic technologies.

The increasing prevalence of cancer is expected to drive the growth of the cancer treatment facilities market in the coming years. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells within the body. This rise in cancer cases is largely attributed to the aging population, as the risk of developing cancer increases significantly with age. Cancer treatment facilities play a crucial role in managing this growing burden by offering early diagnosis, advanced treatment options, and ongoing care, all of which contribute to better patient outcomes and improved quality of life. For example, in February 2023, the Leukaemia Foundation, an Australia-based non-profit organization, reported that between 2022 and 2035, over 7,000 children, 6,000 young adults, and 108,000 adults aged 25 to 65 are expected to be diagnosed with blood cancers such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin lymphoma. As a result, the rising cancer incidence is fueling the expansion of the cancer treatment facilities market.

Companies in the cancer treatment facilities market are increasingly focused on advanced technologies like electron beam therapy to improve precision in cancer care. Electron beam therapy utilizes high-energy electrons to treat cancers located near the body’s surface. For instance, in October 2024, Aster DM Healthcare Limited, a UAE-based healthcare provider, introduced intraoperative electron radiation therapy (IOeRT) for cancer treatment. This method delivers a concentrated, high-dose electron beam directly to the tumor bed during surgery, taking advantage of direct visualization to accurately target any remaining cancer cells while shielding nearby healthy tissues. The use of high-energy electrons, typically ranging from 4 to 12 MeV, allows for a sharp drop-off in radiation dose, thereby minimizing exposure to deeper tissues.

In December 2024, Reliance Industries Limited, an India-based conglomerate, acquired Karkinos Healthcare for $44 million. The acquisition is part of Reliance’s strategy to strengthen its role in the digital healthcare sector and improve access to advanced oncology services across India. Karkinos Healthcare is an Indian company specializing in cancer care technologies and treatment facilities.

Major players in the cancer treatment facilities market are Kaiser Permanente, HCA Healthcare Inc., CommonSpirit Health, Ascension Health, Trinity Health Corporation, Tenet Healthcare Corporation, Adventist Health System Sunbelt Healthcare Corporation, Universal Health Services Inc., Community Health Systems Inc., Ramsay Health Care Limited, Sutter Health, Stanford Health Care, Netcare Limited, Allegheny Health Network, IHH Healthcare Berhad, Fortis Healthcare, LifePoint Health Inc., Aster DM Healthcare Limited, Prime Healthcare Services Inc., and Providence Health & Services.

Asia-Pacific was the largest region in the cancer treatment facilities market in 2024, and it is expected to be the fastest-growing region in the forecast period. The regions covered in cancer treatment facilities report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cancer treatment facilities market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer treatment facilities market includes revenues earned by entities by providing services such as imaging, chemotherapy administration, tumor removal surgeries, pain management, and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cancer treatment facilities market research report is one of a series of new reports that provides cancer treatment facilities market statistics, including cancer treatment facilities industry global market size, regional shares, competitors with a cancer treatment facilities market share, cancer treatment facilities market segments, market trends and opportunities, and any further data you may need to thrive in the cancer treatment facilities industry. This cancer treatment facilities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cancer treatment facilities are specialized healthcare centers dedicated to providing comprehensive care to individuals diagnosed with cancer. These facilities employ advanced medical technologies, skilled healthcare professionals, and evidence-based treatment approaches to effectively diagnose, manage, and treat cancer, with the goal of enhancing patient outcomes and overall quality of life.

The primary types of cancer treatment facilities include those focused on blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, colorectal cancer, lung cancer, and other forms of cancer. Blood cancer originates in the blood or bone marrow and disrupts the normal development and function of blood cells. These facilities support a range of treatment modalities, such as surgical oncology, chemotherapy, radiation therapy, immunotherapy, and bone marrow transplantation. Services are provided by various healthcare entities, including hospitals and specialized cancer centers.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.